PITTSBURGH, June 21, 2025 ~ At the St. Louis Wound & Vascular Symposium today, MolecuLight Corp. is proudly showcasing its innovative multimodal imaging technology with thermal capabilities. The global pioneer in point-of-care fluorescence imaging for wound care invites attendees to experience the transformative capabilities of its MolecuLight DX™ platform at Booth #4.

The one-day event brings together healthcare professionals and industry experts to explore the latest advancements in wound and vascular treatment. MolecuLight is eager to demonstrate how its advanced imaging technology provides clinicians with objective, real-time, and comprehensive information on bacterial presence, wound measurement, and skin temperature changes. This empowers more precise, targeted, and effective treatment decisions.

"We are incredibly excited to engage with the wound care community at the St. Louis Wound & Vascular Symposium," says Anil Amlani, CEO of MolecuLight. "As a conference dedicated to highlighting new treatment advancements, we are proud that MolecuLight's innovative multimodal platform exemplifies these strides in wound care."

More on Missouriar

• Join Springfield Police for Annual Coffee with A Cop
• Springfield: SPD Honors Four Officers Retiring After 25 Years of Service
• Springfield: Coffee with Police Chief Paul Williams
• Springfield Police Department Celebrates Promotions
• Springfield Police Warn of Scam Calls

Amlani continues, "Our devices are truly transforming how clinicians assess wounds by providing vital visual data directly at the point of care. This comprehensive view is essential for optimizing patient outcomes and standardizing best practices. We look forward to demonstrating these powerful capabilities and discussing their clinical impact with attendees at Booth #4."

The MolecuLight DX™ platform is an indispensable tool for wound care specialists globally. Its real-time fluorescence visualization of bacteria, combined with digital wound measurement and new thermal capabilities, provides a comprehensive view for optimizing wound treatments. This includes guiding targeted debridement and sampling for microbiology, assessing thermal patterns for inflammation or perfusion issues, and objectively monitoring wound and treatment progress – ultimately leading to more effective patient care.

MolecuLight's presence at the St. Louis Wound & Vascular Symposium highlights its commitment to advancing wound care through cutting-edge technology. With its multimodal imaging platform, the company is revolutionizing how clinicians assess and treat wounds, ultimately improving patient outcomes. Attendees are encouraged to visit Booth #4 to experience the transformative capabilities of MolecuLight's technology firsthand.

---

Show All News | Report Violation